Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2018

Content (21 Articles)

Editorial

The heterogeneity of cancer

H. Gilbert Welch

Review

Rapid review: radiomics and breast cancer

Francesca Valdora, Nehmat Houssami, Federica Rossi, Massimo Calabrese, Alberto Stefano Tagliafico

Open Access Preclinical study

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

Sara Jansson, Kristina Aaltonen, Pär-Ola Bendahl, Anna-Karin Falck, Maria Karlsson, Kristian Pietras, Lisa Rydén

Preclinical study

Machine learning to parse breast pathology reports in Chinese

Rong Tang, Lizhi Ouyang, Clara Li, Yue He, Molly Griffin, Alphonse Taghian, Barbara Smith, Adam Yala, Regina Barzilay, Kevin Hughes

Preclinical study

Lymph drainage of the upper limb and mammary region to the axilla: anatomical study in stillborns

Guilherme de Arruda Cuadrado, Mauro Figueiredo Carvalho de Andrade, Flávia Emi Akamatsu, Alfredo Luiz Jacomo

Open Access Preclinical study

A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer

Sae Byul Lee, Guiyun Sohn, Jisun Kim, Il Yong Chung, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko, Byung Ho Son, Sei-Hyun Ahn

Preclinical study

Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes

Shunheng Zhou, Lihong Wang, Qian Yang, Haizhou Liu, Qianqian Meng, Leiming Jiang, Shuyuan Wang, Wei Jiang

Open Access Preclinical study

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

Nouf Al-Subhi, Reem Ali, Tarek Abdel-Fatah, Paul M. Moseley, Stephen Y. T. Chan, Andrew R. Green, Ian O. Ellis, Emad A. Rakha, Srinivasan Madhusudan

Clinical trial

Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)–Medicare Registry

Mark Fairweather, Wei Jiang, Nancy L. Keating, Rachel A. Freedman, Tari A. King, Faina Nakhlis

Clinical study

Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma

Anne-Sophie Hamy, Giang-Thanh Lam, Enora Laas, Lauren Darrigues, Thomas Balezeau, Julien Guerin, Alain Livartowski, Benjamin Sadacca, Jean-Yves Pierga, Anne Vincent-Salomon, Florence Coussy, Veronique Becette, Hélène Bonsang-Kitzis, Roman Rouzier, Jean-Guillaume Feron, Gabriel Benchimol, Marick Laé, Fabien Reyal

Clinical trial

A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow

Vincent P. Walter, Florin-Andrei Taran, Markus Wallwiener, Christina Walter, Eva-Maria Grischke, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf

Clinical trial

Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database

Ki-Tae Hwang, Eun-Kyu Kim, Sung Hoo Jung, Eun Sook Lee, Seung Il Kim, Seokwon Lee, Heung Kyu Park, Jongjin Kim, Sohee Oh, Young A. Kim, Sei Hyun Ahn, Dong-Young Noh, Seok Jin Nam, Eun Sook Lee, Byeong-Woo Park, Woo Chul Noh, Jung Han Yoon, Soo Jung Lee, Eun Kyu Lee, Joon Jeong, Sehwan Han, Ho Yong Park, Nam-Sun Paik, Young Tae Bae, Hyouk Jin Lee, Heung kyu Park, Seung Sang Ko, Byung Joo Song, Young Jin Suh, Sung Hoo Jung, Se Heon Cho, Sei Joong Kim, Se Jeong Oh, Byung Kyun Ko, Ku Sang Kim, Chanheun Park, Jong-Min Baek, Ki-Tae Hwang, Il-Sung Chang, Jeoung Won Bae, Jeong-Soo Kim, Sun Hee Kang, Geumhee Gwak, Jee Hyun Lee, Tae Hyun Kim, Myungchul Chang, Sung Yong Kim, Jung Sun Lee, Jeong-Yoon Song, Hai Lin Park, Sun Young Min, Jung-Hyun Yang, Sung Hwan Park, Woo-Chan Park, Lee Su Kim, Dong Won Ryu, Kweon Cheon Kim, Min Sung Chung, Hee Boong Park, Cheol Wan Lim, Un Jong Choi, Beom Seok Kwak, Young Sam Park, Hyuk Jai Shin, Young Jin Choi, Doyil Kim, Airi Han, Jong Hyun Koh, Sangyong Choi, Daesung Yoon, Soo Youn Choi, Shin Hee Chul, Jae Il Kim, Jae Hyuck Choi, Jin Woo Ryu, Chang Dae Ko, Il Kyun Lee, Dong Seok Lee, Seunghye Choi, Youn Ki Min, Young San Jeon, Eun-Hwa Park

Open Access Clinical trial

The frequency of missed breast cancers in women participating in a high-risk MRI screening program

S. Vreemann, A. Gubern-Merida, S. Lardenoije, P. Bult, N. Karssemeijer, K. Pinker, R. M. Mann

Clinical trial

Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer

Julia Foldi, Sarah Mougalian, Andrea Silber, Donald Lannin, Brigid Killelea, Anees Chagpar, Nina Horowitz, Courtney Frederick, Lawrence Rispoli, Trisha Burrello, Maysa Abu-Khalaf, Kert Sabbath, Tara Sanft, Debra S. Brandt, Erin W. Hofstatter, Christos Hatzis, Michael P. DiGiovanna, Lajos Pusztai

Clinical trial

Cross-reactivity between MUC1 antigen and MCA: false elevation of serum CA 15-3 level in pregnant and lactating women by Ma695–Ma552-based assay

Guangshu Liang, Xuqian Fang, Xiaoyi Lin, Xiaojing Feng, Huangying Lu, Yinglei Wan, Zhidong Gu

Open Access Clinical trial

Complications following immediate compared to delayed deep inferior epigastric artery perforator flap breast reconstructions

J. Beugels, L. Bod, S. M. J. van Kuijk, S. S. Qiu, S. M. H. Tuinder, E. M. Heuts, A. Piatkowski, R. R. W. J. van der Hulst

Open Access Epidemiology

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

E. Rakovitch, R. Gray, F. L. Baehner, R. Sutradhar, M. Crager, S. Gu, S. Nofech-Mozes, S. S. Badve, W. Hanna, L. L. Hughes, W. C. Wood, N. E. Davidson, L. Paszat, S. Shak, J. A. Sparano, L. J. Solin

Open Access Epidemiology

A comprehensive tool for measuring mammographic density changes over time

Mikael Eriksson, Jingmei Li, Karin Leifland, Kamila Czene, Per Hall

Brief Report

A novel patient-derived xenograft model for claudin-low triple-negative breast cancer

Margarite D. Matossian, Hope E. Burks, Annie C. Bowles, Steven Elliott, Van T. Hoang, Rachel A. Sabol, Nicholas C. Pashos, Benjamen O’Donnell, Kristin S. Miller, Bahia M. Wahba, Bruce A. Bunnell, Krzysztof Moroz, Arnold H. Zea, Steven D. Jones, Augusto C. Ochoa, Amir A. Al-Khami, Fokhrul Hossain, Adam I. Riker, Lyndsay V. Rhodes, Elizabeth C. Martin, Lucio Miele, Matthew E. Burow, Bridgette M. Collins-Burow

Brief Report

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

Nicholas B. Figura, Wendy Long, Michael Yu, Timothy J. Robinson, Sepideh Mokhtari, Arnold B. Etame, Nam D. Tran, Roberto Diaz, Hatem Soliman, Heather S. Han, Solmaz Sahebjam, Peter A. Forsyth, Kamran A. Ahmed

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine